Anti-Human CD252 Recombinant Antibody (Oxelumab) (CAT#: TAB-223)

Recombinant monoclonal antibody to CD252. Oxelumab is a human monoclonal antibody designed for the treatment of asthma.

Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Tested Data
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
ELISA

Figure 1 Anti-Human CD252 Antibody (Oxelumab) (TAB-223) in ELISA

Figure 1 Anti-Human CD252 Antibody (Oxelumab) (TAB-223) in ELISA

ELISA analysis of TAB-223 was performed by coating with Recombinant Human CD252 Protein.

WB

Figure 2 Anti-Human CD252 Antibody (Oxelumab) (TAB-223) in WB

Figure 2 Anti-Human CD252 Antibody (Oxelumab) (TAB-223) in WB

Western blot analysis of TAB-223 was performed with Recombinant Human CD252 Protein.
Lane 1: Non-Reducing Antigen (1 μg)
Lane 2: Reducing Antigen (1 μg)


Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Human
  • Derivation
  • Human
  • Type
  • IgG1 - kappa
  • Specificity
  • Tested positive against native human antigen.
  • Species Reactivity
  • Human
  • Applications
  • Suitable for use in WB, IP, IF, FuncS, FC, Neut, ELISA and most other immunological methods.
  • CAS
  • 1186098-83-8
  • Generic Name
  • Oxelumab
  • MW
  • 144.6 kDa
  • Related Disease
  • Asthma

Product Property

  • Purity
  • >95.0%, determined by analysis by RP-HPLC & analysis by SDS-PAGE.
  • Storage
  • Store at 4°C for up to 3 months. For longer term storage aliquot into small volumes and store at -20°C.

Target

  • Alternative Names
  • Oxelumab;1186098-83-8;RO4989991;RG4930;huMAb OX40L;TNFSF4;tumor necrosis factor (ligand) superfamily, member 4;tax transcriptionally activated glycoprotein 1, 34kD , TXGP1;tumor necrosis factor ligand superfamily member 4;CD252;gp34;OX 40L;OX40L;CD134 lig

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Oxelumab"

Afuco™ Anti-TNFSF4 ADCC Recombinant Antibody (Oxelumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to CD252. Oxelumab is a human monoclonal antibody designed for the treatment of asthma.

See other products for "TNFSF4"

Select a product category from the dropdown menu below to view related products.
Please select product type
Recombinant Antibody Single-domain Antibody Mouse Antibody Human Antibody Blocking Antibody Neutralizing Antibody Rabbit Monoclonal Antibody scFv Fragment Antibody Fab Fragment Antibody ADCC Enhanced Antibody

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for TAB-223. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare